SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001831283-23-000092
Filing Date
2023-06-23
Accepted
2023-06-23 16:17:52
Documents
12
Period of Report
2023-06-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K lian-20230621.htm   iXBRL 8-K 34960
  Complete submission text file 0001831283-23-000092.txt   170262

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lian-20230621.xsd EX-101.SCH 1901
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lian-20230621_lab.xml EX-101.LAB 25850
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lian-20230621_pre.xml EX-101.PRE 13581
6 EXTRACTED XBRL INSTANCE DOCUMENT lian-20230621_htm.xml XML 4479
Mailing Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540 (609) 486-2308
LianBio (Filer) CIK: 0001831283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40947 | Film No.: 231037914
SIC: 2834 Pharmaceutical Preparations